Patent directory · USPTO A61K / A61P
Patents matching “GANYMED PHARMACEUTICALS AG [DE]”
9 pharma patents match "GANYMED PHARMACEUTICALS AG [DE]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 9 pharmaceutical patents matching "GANYMED PHARMACEUTICALS AG [DE]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 2018326059
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
granted -
US 2018000900
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
granted -
US 2016185873
MONOCLONAL ANTIBODIES FOR TREATMENT OF CANCER
granted -
US 2016159901
DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS
granted -
EP 2976360
THERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS
granted -
EP 2958945
KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS
granted -
EP 2852409
KOMBINATIONSTHERAPIE MIT ANTIKÖRPERN GEGEN CLAUDIN 18.2 ZUR BEHANDLUNG VON KREBS
granted -
EP 2847225
ANTIKÖRPER GEGEN CLAUDIN 18.2 FÜR DIE KREBSDIAGNOSE
granted -
EP 2591003
KREBSTHERAPIE MITTELS CLDN6-ZIELGERICHTETER ANTIKÖRPER IN VIVO
granted